
by Biospring | May 30, 2022 | Curie Bio, EHR, Flatiron Health, Pharma, RWD, RWE, Zach Weinberg
Zach Weinberg is a Co-Founder of Curie Bio and Operator Partners. Zach was previously Co-Founder, President, and COO of both Flatiron Health (acquired by Roche in 2018 for $2B) and Invite Media (acquired by Google in 2010 for $81M). Zach is one of the most successful...
by Biospring | Apr 26, 2022 | Artificial Intelligence, Data, Drug Discovery, Health Care, John Baldoni, Pharma
We recently hosted a discussion with Dr. John Baldoni, one of Biospring’s Operational Experts. He is the Co-Founder and Chief Scientific Officer of SaponiQx, a recently formed vaccine discovery and development company. He’s also the CEO of the Atom...
by Biospring | Apr 26, 2022 | Biotech, Cell and Gene Therapy, Cell Therapy, CGT, Gene Therapy, Pharma
What if instead of treating the symptoms of a disease, we could target the source of the disease itself? Cell and Gene Therapy (C>) can do just that. These advanced therapies are the result of decades of research on the building blocks (cells) and blueprints...
by Biospring | Apr 25, 2022 | DNA, Drug Development, Drug Discovery, Manufacturing, Pharma, Supply Chain, Sybio, Synthetic Biology
Synthetic biology (synbio) is a life sciences technology that is transforming a broad range of industries including agriculture, chemicals, food, and medicine. Synbio applies engineering principles to biology and uses genomics to “code” organisms to yield a desired...
by Biospring | Apr 25, 2022 | Abzena, Biologics, Biotech, CDMO, COVID-19, Drug Development, Drug Discovery, Drug Manufacturing, Pharma, Sven Lee
We shared an overview on Abzena following our investment in July. Over the past few months, Abzena has launched a new facility in San Diego and has made several executive hires. We recently spoke with Sven Lee, Chief Business Officer at Abzena, and he provided us with...
by Biospring | Apr 24, 2022 | Chemistry, Computer Aided Molecular Design, Drug Design, Graham Richards, Oxford, Pharma
Professor Graham Richards is Commander of the Order of the British Empire and former Head of Chemistry at the University of Oxford. He is a pioneer in the field of computational chemistry and computer-aided molecular design, particularly as it applies to the...